IBB250516C125000
- 3.20
- +0.40+14.29%
iShares Biotechnology ETF Newsroom
Earnings Call Summary | Vertex Pharmaceuticals(VRTX.US) Q1 2025 Earnings Conference
Vertex Misses on Both Lines in Q1 as 2025 Revenue Forecast Narrowed
Here Are the Major Earnings Before the Open Tomorrow
Vertex Pharmaceuticals Stock Falls On Q1 Earnings, Revenue Miss — Company Raises Low End Of FY25 Revenue Guidance
Vertex Pharmaceuticals Non-GAAP EPS of $4.06 Misses by $0.23, Revenue of $2.77B Misses by $90M
Vertex Has Lost Some Sizzle Into Q1 Earnings - Can Alyftrek, Journavx Reignite The Momentum?
If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today
Why Is Israel-Based Generic Drug Focused Teva Pharmaceutical Stock Trading Higher On Monday?
IQVIA Q1 2025 Earnings Preview
These Are the Sectors Best Liked Within Defensive and Cyclicals Groups – Morgan Stanley
Vertex Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Here Are the Major Earnings After the Close Today
Sector Update: Health Care Stocks Decline Pre-Bell Monday
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as Investors Brace for Fed Decision
Mettler-Toledo Intl Analyst Ratings
Earnings Scheduled For May 5, 2025
Vertex Pharmaceuticals Q1 2025 Earnings Preview
Notable Healthcare Headlines for the Week: Gilead, CVS Health, Sanofi in Focus
Earnings Week Ahead: AMD, PLTR, F, DIS, SHOP, DKNG, AMC, LCID, GOLD, RIVN, and More
Healthcare Sector Flexes Earnings Muscle, but Top-line Cracks Show